ZA745443B - Novel preparations containing n-(2-furfuryl)-4-chloro-5-sulfamoyl-anthranilic acid and process for their manufacture - Google Patents
Novel preparations containing n-(2-furfuryl)-4-chloro-5-sulfamoyl-anthranilic acid and process for their manufactureInfo
- Publication number
- ZA745443B ZA745443B ZA00745443A ZA745443A ZA745443B ZA 745443 B ZA745443 B ZA 745443B ZA 00745443 A ZA00745443 A ZA 00745443A ZA 745443 A ZA745443 A ZA 745443A ZA 745443 B ZA745443 B ZA 745443B
- Authority
- ZA
- South Africa
- Prior art keywords
- furfuryl
- sulfamoyl
- chloro
- manufacture
- preparations containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2343218A DE2343218C2 (de) | 1973-08-28 | 1973-08-28 | Furosemid enthaltende Pellets |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA745443B true ZA745443B (en) | 1975-08-27 |
Family
ID=5890849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA00745443A ZA745443B (en) | 1973-08-28 | 1974-08-26 | Novel preparations containing n-(2-furfuryl)-4-chloro-5-sulfamoyl-anthranilic acid and process for their manufacture |
Country Status (17)
Country | Link |
---|---|
US (1) | US4324779A (fi) |
JP (1) | JPS563849B2 (fi) |
AT (1) | AT344914B (fi) |
BE (1) | BE819294A (fi) |
CA (1) | CA1063024A (fi) |
DE (1) | DE2343218C2 (fi) |
DK (1) | DK155173B (fi) |
EG (1) | EG14662A (fi) |
FI (1) | FI249774A (fi) |
FR (1) | FR2242076B1 (fi) |
GB (1) | GB1478715A (fi) |
HU (1) | HU171769B (fi) |
IL (1) | IL45521A (fi) |
MX (1) | MX3585E (fi) |
NL (1) | NL7411269A (fi) |
SE (1) | SE7410788L (fi) |
ZA (1) | ZA745443B (fi) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI65910C (fi) * | 1976-11-26 | 1984-08-10 | Pennwalt Corp | Foerfarande foer framstaellning av farmaceutiska preparat med laongtidsverkan |
GB1561204A (en) * | 1977-06-01 | 1980-02-13 | Ici Ltd | Sustained release pharmaceutical composition |
US4773907A (en) * | 1982-12-20 | 1988-09-27 | Alza Corporation | Primary delivery system comprising secondary dosage form |
US4681583A (en) * | 1982-12-20 | 1987-07-21 | Alza Corporation | System for dispersing drug in biological environment |
US4578075A (en) * | 1982-12-20 | 1986-03-25 | Alza Corporation | Delivery system housing a plurality of delivery devices |
DE3305935C2 (de) * | 1983-02-21 | 1985-05-30 | Medice Chem.-Pharm. Fabrik Pütter GmbH & Co KG, 5860 Iserlohn | Kaliumneutrales Saluretikum mit antihypertensiver Wirkung |
IE55745B1 (en) * | 1983-04-06 | 1991-01-02 | Elan Corp Plc | Sustained absorption pharmaceutical composition |
US4663348A (en) * | 1985-07-02 | 1987-05-05 | Warner-Lambert Co. | Furosemide salts and pharmaceutical preparations thereof |
SE460947B (sv) * | 1986-08-26 | 1989-12-11 | Lejus Medical Ab | En multiple-unit-dos komposition av l-dopa |
JPH01130957U (fi) * | 1988-02-29 | 1989-09-06 | ||
JPH0710747A (ja) * | 1993-04-28 | 1995-01-13 | Takeda Chem Ind Ltd | 固形製剤およびその製造方法 |
GB2281697A (en) * | 1993-09-14 | 1995-03-15 | Euro Celtique Sa | Laxative compositions in capsules |
US20070059358A1 (en) * | 2003-07-02 | 2007-03-15 | Tianjin Tasly Pharmaceutical Co., Ltd., China | Matrix adjuvants and the drop pills prepared with them |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3058882A (en) * | 1959-12-28 | 1962-10-16 | Hoechst Ag | N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof |
US3361632A (en) * | 1964-05-08 | 1968-01-02 | Hoechst Ag | Medicinal preparations having a protracted activity and method of making them |
US3456049A (en) * | 1965-05-25 | 1969-07-15 | Ciba Geigy Corp | Gradual-release tablet |
US3857933A (en) * | 1969-10-17 | 1974-12-31 | Hoechst Ag | Process for the manufacture of a drug dosage form permitting controlled release of active ingredient |
DE2010416B2 (de) * | 1970-03-05 | 1979-03-29 | Hoechst Ag, 6000 Frankfurt | Oral anwendbare Arzneiform mit Retardwirkung |
-
1973
- 1973-08-28 DE DE2343218A patent/DE2343218C2/de not_active Expired
-
1974
- 1974-08-23 IL IL45521A patent/IL45521A/xx unknown
- 1974-08-23 GB GB37157/74A patent/GB1478715A/en not_active Expired
- 1974-08-23 NL NL7411269A patent/NL7411269A/xx active Search and Examination
- 1974-08-26 JP JP9713274A patent/JPS563849B2/ja not_active Expired
- 1974-08-26 EG EG355/74A patent/EG14662A/xx active
- 1974-08-26 SE SE7410788A patent/SE7410788L/xx unknown
- 1974-08-26 FI FI2497/74A patent/FI249774A/fi unknown
- 1974-08-26 ZA ZA00745443A patent/ZA745443B/xx unknown
- 1974-08-27 MX MX742666U patent/MX3585E/es unknown
- 1974-08-27 AT AT694274A patent/AT344914B/de not_active IP Right Cessation
- 1974-08-27 DK DK455274AA patent/DK155173B/da not_active Application Discontinuation
- 1974-08-27 HU HU74HO00001710A patent/HU171769B/hu unknown
- 1974-08-27 CA CA207,950A patent/CA1063024A/en not_active Expired
- 1974-08-28 BE BE147988A patent/BE819294A/xx not_active IP Right Cessation
- 1974-08-28 FR FR7429442A patent/FR2242076B1/fr not_active Expired
-
1979
- 1979-09-20 US US06/077,181 patent/US4324779A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
SE7410788L (fi) | 1975-03-03 |
CA1063024A (en) | 1979-09-25 |
IL45521A (en) | 1978-07-31 |
US4324779A (en) | 1982-04-13 |
AT344914B (de) | 1978-08-25 |
FR2242076B1 (fi) | 1978-07-28 |
ATA694274A (de) | 1977-12-15 |
DK155173B (da) | 1989-02-27 |
IL45521A0 (en) | 1974-11-29 |
JPS5076217A (fi) | 1975-06-21 |
MX3585E (es) | 1981-03-20 |
NL7411269A (nl) | 1975-03-04 |
DE2343218A1 (de) | 1975-04-03 |
EG14662A (en) | 1984-09-30 |
AU7272874A (en) | 1976-03-04 |
HU171769B (hu) | 1978-03-28 |
DK455274A (fi) | 1975-04-28 |
GB1478715A (en) | 1977-07-06 |
JPS563849B2 (fi) | 1981-01-27 |
FR2242076A1 (fi) | 1975-03-28 |
FI249774A (fi) | 1975-03-01 |
BE819294A (fr) | 1975-02-28 |
DE2343218C2 (de) | 1986-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA745443B (en) | Novel preparations containing n-(2-furfuryl)-4-chloro-5-sulfamoyl-anthranilic acid and process for their manufacture | |
IL45294A0 (en) | 7-acylamido-3-cephem-4-carboxylic acid derivatives and process for their preparation | |
GB1484606A (en) | Substituted amino-benzoic acid derivatives and process for their manufacture | |
AU7658674A (en) | New prostanoic acid derivatives and process for their manufacture | |
AU8176175A (en) | Pyrazolobenzazepines, process for their manufacture and pharmaceutical preparations containing them | |
IL45628A0 (en) | New pyrazolyloxyacetic acid derivatives and process for their manufacture | |
ZA745912B (en) | Novel prostanoic acids and process for their manufacture | |
IL41811A0 (en) | Thiocarbamic acid derivatives and process for their preparation | |
CA1021348A (en) | Oligocarboxy-alkan-phosphonic acid and process for making them | |
IL45603A0 (en) | 7-trichloroacetamido-3-desacetoxy-cephalosporanic acid derivatives and processes for their preparation | |
IL46064A0 (en) | Production of solid preparations containing carbochromene hydrochloride | |
MW1674A1 (en) | Process for the preparation of citric acid and derivativesthereof | |
EG11252A (en) | Process for preparing of n-(aminoacylaminophenyl)acetamidines | |
ZA757368B (en) | New 7,7-diphenyl-hexahydro-1,4-oxazepines,process for their manufacture and pharmaceutical preparations containing them | |
CA982603A (en) | Process for preparing acid amides and pharmaceutical compositions containing same | |
AU488467B2 (en) | Preparations containing n-(2-furfuryl) 4-chloro 5-sulfamoyl-anthranilic acid and process for their manufacture | |
ZA737959B (en) | New 4-ethers of 3-amino-5-sulfamoyl-benzoic acids,process for their manufacture and pharmaceutical preparations containing them | |
EG11957A (en) | Process for the preparation of otaconic acid and derivatives thereof | |
IL45602A0 (en) | 6-trichloroacetamido-penicillanic acid derivatives and processes for their preparation | |
IL45605A0 (en) | 7-monochloroacetamido-3-desacetoxy-cephalosporanic acid derivatives and processes for their preparation | |
ZA744182B (en) | 7-acylamido-3-cephem-4-carboxylic acid derivatives and process for their preparation | |
KE2891A (en) | Diphenoxyacetic acid derivatives and processes for their preparation | |
IL45604A0 (en) | 6-monochloroacetamido-penicillanic acid derivatives and processes for their preparation | |
AU483801B2 (en) | New 4-ethers of 3-amino-5-sulfamoyl-benzoic acids, process for their manufacture and pharmaceutical preparations containing them | |
CS191425B1 (en) | Process for preparing and isolating p-benzaldehydcarbonic acid |